ENTITY
Shanghai Henlius Biotech

Shanghai Henlius Biotech (2696 HK)

317
Analysis
Health Care • China
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
bullish•SLB Development
•28 Jan 2025 11:51

SLB Dev (SLB SP): Ong Family Offer By Way Of A Scheme.

This is done. Trading tight at a 2.2%/7.2% gross/annualised spread, if payment late May. If small-cap illiquid arbs are your bent, get involved.

Logo
482 Views
Share
bearish•WH Group
•28 Jan 2025 09:16

WH Group (288 HK) Is Stretched As Smithfield Mulls IPO Price Reduction

A US$10bn market cap for Smithfield was punchy. Reportedly, the feedback from investors think likewise. Dumbing down the bottom end of the price...

Logo
511 Views
Share
bullish•Suntec REIT
•27 Jan 2025 09:45

Suntec REIT (SUN SP): Tang's Curious Bump

After the Tangs bumped to S$1.19/share on the 8th January, the IFA, with a fair value range of S$2.07-S$2.26, concluded on the 17th January that...

Logo
934 Views
Share
•27 Jan 2025 09:24

CNBM (3323 HK): This Is An "Avoid" Ahead Of 19th Feb H-Class Shareholder Vote

If ~45% of independent H-share class shareholders tenders, pro-ration would be ~42%, implying a back-end B/E price of HK$3.28/share.This is an...

Logo
596 Views
Share
bullish•Seven & I Holdings
•26 Jan 2025 15:32

Weekly Deals Digest (26 Jan) - Seven & I, Shinko, Canvest, GAPack, Get Nice, Japfa, LG CNS, Guming

Last week, notable developments occurred in Event-Driven (Canvest, Henlius, GAPack, Get Nice, Seven & I, Shinko Electric, Fuji Soft, Japfa,...

Logo
566 Views
Share
x